Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia (Q66033718)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia |
clinical trial |
Statements
Phase II Study of the Efficacy of rH Interleukin-2 in Patients With Slowly Progressing Acute Myelogenous Leukemia (AML) and With Limited Bone Marrow Blastosis After Autologous Stem Cell Transplantation or Chemotherapy (English)
0 references
October 1997
0 references
April 2001
0 references
86
0 references
18 year
0 references
60 year
0 references